Literature DB >> 2297657

Hepatosplenic candidiasis in children with acute leukemia.

A Verdeguer1, J M Fernández, C Esquembre, J Ferris, J G Ruiz, V Castel.   

Abstract

Three children with acute lymphoblastic leukemia developed disseminated fungal disease predominantly involving the liver and spleen. The three patients were undergoing induction chemotherapy and had neutropenia when they presented prolonged fever not responsive to antibiotics. Once neutropenia was recovered, hepatosplenomegaly leukocytosis, elevated serum alkaline phosphatase, and hypoechoic areas in the spleen and liver ultrasound were observed. All fungal blood cultures were negative, with the diagnosis being confirmed by histologic study. One of the patients died without achieving control of the candidiasis. The other two patients received prolonged antifungal treatment concurrently with chemotherapy and both are alive, one of them cured and in complete remission. The increasing frequency of this infection in recent years and the importance of a prompt and prolonged administration of antifungal therapy to obtain the cure are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2297657     DOI: 10.1002/1097-0142(19900215)65:4<874::aid-cncr2820650408>3.0.co;2-z

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Evaluation of a murine model of hepatic candidiasis.

Authors:  G T Cole; K T Lynn; K R Seshan
Journal:  J Clin Microbiol       Date:  1990-08       Impact factor: 5.948

2.  Hepatosplenic candidasis, a fatal disease?

Authors:  A Loeliger; M van Leeuwen; M Rozenberg-Arska; A W Dekker
Journal:  Infection       Date:  1992-11       Impact factor: 3.553

3.  Gamma interferon is not essential in host defense against disseminated candidiasis in mice.

Authors:  Q Qian; J E Cutler
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

4.  Liposomal amphotericin B in hepatic candidosis.

Authors:  M Sharland; R J Hay; E G Davies
Journal:  Arch Dis Child       Date:  1994-06       Impact factor: 3.791

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.